BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1455 related articles for article (PubMed ID: 8851162)

  • 1. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
    Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
    Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
    Paronis CA; Woods JH
    Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats.
    Mao J; Price DD; Lu J; Mayer DJ
    Neurosci Lett; 1998 Jul; 250(3):193-6. PubMed ID: 9708865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
    Le Guen S; Catheline G; Besson JM
    Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
    Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
    Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
    Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
    Haghparast A; Gheitasi IP; Lashgari R
    Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats.
    Wen ZH; Chang YC; Cherng CH; Wang JJ; Tao PL; Wong CS
    Brain Res; 2004 Jan; 995(2):253-9. PubMed ID: 14672815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice.
    Zushida K; Kamei J
    Eur J Pharmacol; 2002 Jul; 448(1):39-44. PubMed ID: 12126969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse.
    Suh H; Song D; Huh S; Kim YH
    Brain Res Bull; 2000 May; 52(2):143-50. PubMed ID: 10808085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain.
    Zahn PK; Brennan TJ
    Anesthesiology; 1998 Jan; 88(1):143-56. PubMed ID: 9447867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.